Navigation Links
T-cell therapy eradicates an aggressive leukemia in 2 children
Date:3/25/2013

Two children with an aggressive form of childhood leukemia had a complete remission of their diseaseshowing no evidence of cancer cells in their bodiesafter treatment with a novel cell therapy that reprogrammed their immune cells to rapidly multiply and destroy leukemia cells. A research team from The Children's Hospital of Philadelphia and the University of Pennsylvania published the case report of two pediatric patients Online First today in The New England Journal of Medicine. It will appear in the April 18 print issue.

One of the patients, 7-year-old Emily Whitehead, was featured in news stories in December 2012 after the experimental therapy led to her dramatic recovery after she relapsed following conventional treatment. Emily remains healthy and cancer-free, 11 months after receiving bioengineered T cells that zeroed in on a target found in this type of leukemia, called acute lymphoblastic leukemia (ALL).

The other patient, a 10-year-old girl, who also had a complete response to the same treatment, suffered a relapse two months later when other leukemia cells appeared that did not harbor the specific cell receptor targeted by the therapy.

"This study describes how these cells have a potent anticancer effect in children," said co-first author Stephan A. Grupp, M.D., Ph.D., of The Children's Hospital of Philadelphia, where both patients were treated in this clinical trial. "However, we also learned that in some patients with ALL, we will need to further modify the treatment to target other molecules on the surface of leukemia cells."

Grupp is the director of Translational Research for the Center for Childhood Cancer Research at The Children's Hospital of Philadelphia, and a professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. Michael Kalos, Ph.D., an adjunct associate professor in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine at Pen
'/>"/>

Contact: Rachel Salis-Silverman
Salis@email.chop.edu
267-426-6063
Children's Hospital of Philadelphia

Holly Auer
holly.auer@uphs.upenn.edu
215-200-2313
Perelman School of Medicine, University of Pennsylvania


Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Infusion of stem cells and specially generated T-cells from same donor improves leukemia survival
2. Denosumab reduces burden of giant-cell tumor of the bone
3. Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas
4. UCLA, Caltech research on immune-cell therapy could strengthen promising melanoma treatment
5. Physical therapy as effective as surgery for torn meniscus and arthritis of the knee
6. PREFERRED Therapy Providers Selects WebOutcomes to Deliver Web-Based Outcomes for Their National Provider Network
7. Gene Therapy for Human Disease: Clinical Advances and Challenges
8. Immune Therapy Shows Early Promise for Advanced Leukemia
9. Dennis R. Hill MD Announces Launch of High Dose Rate Brachytherapy of Prostate Cancer Website
10. Therapy as Good as Surgery for Some With Torn Knee Cartilage
11. Women's Excellence in Pelvic Floor Physical Therapy Near Pontiac, MI, Now Offers Therapy After Vaginal Delivery to Prevent Urinary Incontinence, Improve Sexual Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... FCPX developers have announced a ... , “Pro3rd Hue is a lower 3rd pack with a ... Film Studios. “Blurring the line between professional and armature, Pro3rd ... a set of 30 customizable lower third presets made exclusively ... FCPX users can complement any design with a clean and ...
(Date:3/6/2015)... 06, 2015 Dr. Mark Sowell recently returned ... Scottsdale, AZ. Offering programs for advanced education in the field ... world. , As a visiting faculty member of this ... learn” each time he visits Spear Education to participate in ... remarks, “we are training only the top 10% and those ...
(Date:3/6/2015)... March 06, 2015 As the Mayo ... be discussed, Ford & Associates Nationwide Legal Services, A.P.C., ... 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., Case ... California. , “In light of a recently filed ... Benicar to evaluate and explore the Mayo Clinic's Benicar ...
(Date:3/5/2015)... 2015 In 2014, the FDA approved ... tops the list scoring 4 drug approvals in the ... all FDA approved drug products, followed by oncology therapy ... anti-PCSK9, anti-PD1 and CDK inhibitors keep on attracting large-cap ... FDA to treat metastatic melanoma, and at present, they ...
(Date:3/5/2015)... Diego, CA (PRWEB) March 05, 2015 ... levels of formaldehyde in low-cost laminate flooring ... the leading manufacturer of eco-friendly building materials made ... customer safety by testing all their flooring products ... emissions detection laboratory Benchmark International (BMH). ...
Breaking Medicine News(10 mins):Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2
... 2009 Budget Blueprint ,Most Unreasonable, Most Unrealistic, of,Entire ... Reacting to the formal,unveiling of the Bush Administration,s ... (AHCA) said the proposal is unreasonable from the,standpoint ... the face of worsening economic conditions in states ...
... Pairs of Shoes Symbolizing Deaths Caused by Tobacco,Use in ... the,statewide youth advocacy group H.O.T. (Helping Overcome Tobacco) will,gather ... Capitol Rotunda to,highlight the problem of tobacco use in ... on the steps of the Capitol, representing the,number of ...
... to Disclose Political Activism, ALEXANDRIA, Va., Feb. ... from the American Academy of Pediatrics,(AAP) on infant ... today criticized the report as a document motivated ... the report "conveniently" omitting,well-known scientific risk assessments on ...
... A multi-institutional study led by researchers at Cincinnati Childrens ... a model to help unravel the cause of fibrous, ... disfigurement and in rare cases death by compressing vital ... their findings also provide a means for testing therapies ...
... likely to have blood pressure under control, study finds , , ... kidney disease and high blood pressure, black men are least ... them at risk of life-threatening complications, a new study says. ... both black men and women were less likely than white ...
... Association Kicks Off National Children,s Dental Health,Month With Outreach ... February is National,Children,s Dental Health Month. It,s sponsored ... awareness among families and policymakers,about the critical importance to ... sixth year in a row, the ADA opened the ...
Cached Medicine News:Health News:Bush Budget Represents 'Double Whammy' Hit on U.S. Seniors' Medicare-Financed Nursing Facility Care 2Health News:Conflict of Interest in American Academy of Pediatrics Report 2Health News:Conflict of Interest in American Academy of Pediatrics Report 3Health News:Model found to determine cause, possible treatment of nerve tumors 2Health News:Black Men Most at Risk for Kidney Disease Complications 2Health News:A Reminder to Parents: Early Dental Visits Essential to Children's Health 2Health News:A Reminder to Parents: Early Dental Visits Essential to Children's Health 3
(Date:3/5/2015)... BAUDETTE, Minn. , March 5, 2015 /PRNewswire/ ... ) today announced that it has acquired the ... Acetate tablets USP 50mg, 100mg and 150mg, previously ... the overall market for this product was approximately ... Arthur S. Przybyl , President and CEO of ...
(Date:3/5/2015)... and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ) has announced ... Accelerating growth to the next level - Moving up ... offering. Domestic sales improved in 2014, ... the market,s reaction to the new drug pricing policy. ... healthy, as the momentum continues and improving economic growth ...
(Date:3/5/2015)... 2015 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... developing products that address unmet medical needs in the ... its President and Chief Executive Officer, Christopher J. ... the 27 th Annual ROTH Conference in ... 10, 2015 at 1:00 PM Pacific Daylight Time (PDT).  ...
Breaking Medicine Technology:ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3
... 2011 The 23rd Annual Transcatheter Cardiovascular Therapeutics ... Development, Ltd. ("SMT") today announced that Shuki Porath has ...  Mr. Porath will be responsible for overseeing the day-to-day ... Herzliya Pituach, Israel, and will also play a key ...
... 8, 2011 Ikaria, Inc., a critical care company ... address the significant needs of critically ill patients in ... Chairman and CEO, Daniel Tasse, will present at the ... Tasse,s presentation will be given on Tuesday, November 15, ...
Cached Medicine Technology:SMT Research & Development, Ltd. Names Shuki Porath as Vice President and General Manager, Announces TCT Presence 2SMT Research & Development, Ltd. Names Shuki Porath as Vice President and General Manager, Announces TCT Presence 3Ikaria® to Present at 2011 Lazard Capital Markets Healthcare Conference 2
Lyphochek Tumor Marker Control is a comprehensive, bilevel product designed to assess the performance of various cancer antigen tests, including esoteric tumor markers....
... Control provides the clinical laboratory with ... world for monitoring immunoassay and therapeutic ... for separate controls. Made from human ... is suitable for most methods and ...
Liquichek Immunology Control is a trilevel, liquid, comprehensive serum protein control with assayed values for a wide number of methods....
Invacare 5 Oxygen Concentrator with Sens O2, 230 VAC - Intl....
Medicine Products: